Education
About Us
Working with TipRanks
Follow Us
Ingmar Bruns Insider Profile
11 Followers
Ingmar Bruns, CMO at Zentalis Pharmaceuticals, holds 33.33K shares in Zentalis Pharmaceuticals (Ticker: ZNTL). Most recently, Ingmar Bruns Sold 3,297 shares of Zentalis Pharmaceuticals on Feb 10, 2026 for an estimated value of $7.97K.
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+5.70%
Average return per transaction
Time Frame
Compare to
Insider Roles
CMO
Roles that Ingmar Bruns holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Feb 12, 2025 - Feb 12, 2026
Return:+11.10%
The most profitable trade made by Ingmar Bruns
Ingmar Bruns's Trading History
List of latest transactions for each holding click on a transaction to see Ingmar Bruns's performance on stock
You May Also Like
Ingmar Bruns insider profile FAQ
What is the percentage of profitable transactions made by Ingmar Bruns?
The percentage of profitable transactions made by Ingmar Bruns is 100%.
What is the average return per transaction made by Ingmar Bruns?
The average return per transaction made by Ingmar Bruns is 5.70%.
What stocks does Ingmar Bruns hold?
Ingmar Bruns holds: ZNTL stocks.
What was Ingmar Bruns’s latest transaction?
Ingmar Bruns latest transaction was an Informative Sell of $7.97K.
What was Ingmar Bruns's most profitable transaction?
Ingmar Bruns’s most profitable transaction was an Informative Buy of ZNTL stock on February 12, 2025. The return on the trade was 11.10%.
What is Ingmar Bruns's role in Zentalis Pharmaceuticals?
Ingmar Bruns's role in Zentalis Pharmaceuticals is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.